On the making waves article: The autor refers to Daxxy as a candidate and fails to mention that the drug is a) not a candidate but a drug for sale and b) we are beyond phase III we are selling since Q4 23. What an amateure.
"Its drug candidate, DaxibotulinumtoxinA for injection, has completed phase III clinical trials for the treatment of glabellar lines and cervical dystonia and is currently undergoing phase II clinical trials to treat upper facial lines and dynamic forehead and lateral canthal lines."